SCHEMBL18157760

SCHEMBL18157760

C(#Cc1c(/C=C/c2ccccc2)[nH]c2ccccc12)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 9/20 0.40
RAB9A P51151 8/20 0.40
MEN1 O00255 7/20 0.40
KMT2A Q03164 7/20 0.40
MAPT P10636 7/20 0.40
KDM4E B2RXH2 6/20 0.40
GLA P06280 4/20 0.40
ATM Q13315 3/20 0.40
L3MBTL1 Q9Y468 3/20 0.40
NPSR1 Q6W5P4 2/20 0.40
ALK Q9UM73 1/20 0.40
MAPK1 P28482 1/20 0.40
FFAR1 O14842 1/20 0.37
CYP19A1 P11511 1/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2D6 P10635 2/20 0.37
HTT P42858 2/20 0.37
LMNA P02545 2/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18157757 0.76 NPC1 (0.43) NPC1RAB9AMEN1KMT2AMAPT
Diphenylacetylene SCHEMBL15666790 0.74 APP (0.67) MEN1KMT2AMAPTFFAR1CYP19A1
SCHEMBL28555372 0.74 NPC1 (0.50) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL18157755 0.74 NPC1 (0.50) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL18157767 0.74 APP (0.44) MEN1KMT2AMAPTKDM4EGLA
SCHEMBL4892717 0.72 CYP19A1 (0.64) MEN1KMT2AMAPTKDM4ENPSR1
(Z)-1,2-Diphenylethene SCHEMBL4393598 0.72 ALDH1A1 (0.67) NPC1RAB9AMEN1KMT2AMAPT
Diphenylacetylene SCHEMBL6544119 0.72 ALDH1A1 (0.67) MEN1KMT2AMAPTKDM4EGLA
(Z)-1,2-Diphenylethene SCHEMBL4393600 0.72 ALDH1A1 (0.67) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL18160163 0.71 ESR1 (0.55) NPC1RAB9AMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10239834-B2 Antibiotic sensitivity-restoring and photosensitive agents NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION (US) 2019-03-26 US disclosed
US-20180155286-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2018-06-07 US disclosed
US-20180155286-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2018-06-07 US disclosed
US-9834514-B2 Antibiotic sensitivity-restoring and photosensitive agents NEW MEXICO TECH RESEARCH FOUNDATION (US) 2017-12-05 US disclosed
US-9834514-B2 Antibiotic sensitivity-restoring and photosensitive agents NEW MEXICO TECH RESEARCH FOUNDATION (US) 2017-12-05 US disclosed
WO-2016172193-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH RESEARCH FOUNDATION (US) 2016-10-27 WO disclosed
US-20160304453-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS NEW MEXICO TECH UNIVERSITY RESEARCH PARK CORPORATION 2016-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10239834-B2 Antibiotic sensitivity-restoring and photosensitive agents XPA, PPOX, ALAD NPC1 1892/4885RAB9A 679/4885MEN1 1398/4885
US-20180155286-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS XPA, PPOX, ALAD NPC1 1892/4885RAB9A 679/4885MEN1 1398/4885
US-20160304453-A1 ANTIBIOTIC SENSITIVITY-RESTORING AND PHOTOSENSITIVE AGENTS XPA, PPOX, ALAD NPC1 1892/4885RAB9A 679/4885MEN1 1398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.